MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Jackie Reeve Jackie Reeve ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Hannah Morrill Hannah Morrill is an editor covering gifts and beauty. After ...

What happens after you write and submit a review? Learn how advanced AI helps publish authentic reviews and weed out the fakes. Customer reviews have been a core part of why customers love shopping in ...

FUROSCIX ReadyFlow Autoinjector Could Transform Care from Hours to Seconds MannKind recently announced that the FDA accepted for review its sNDA for the FUROSCIX ReadyFlow Autoinjector for the ...